DAFNA Capital Management’s Acer Therapeutics Inc ACER Stock Holding History

DAFNA Capital Management’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6	Closed	–	–	83
2015 Q1	$0	Buy	+6	New	+$368	﹤0.01%	78

Other funds holding ACER

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

DAFNA Capital Management's ACER Position: Q2 2015 in Review

DAFNA Capital Management sold out of Acer Therapeutics Inc (ACER) in Q2 2015, closing a stake of 6 shares.

DAFNA Capital Management first reported a position in ACER in Q1 2015 and held it in 1 quarter. The position peaked at $0 in Q1 2015. 16 funds tracked by Wall St. Rank hold ACER as of Q2 2015.

DAFNA Capital Management reported no remaining Acer Therapeutics Inc position as of Q2 2015 after selling out during the quarter.
DAFNA Capital Management sold 6 Acer Therapeutics Inc shares in Q2 2015.
DAFNA Capital Management first reported a position in Acer Therapeutics Inc in Q1 2015 and held it in 1 quarter.
DAFNA Capital Management's Acer Therapeutics Inc position peaked at $0 in Q1 2015.
16 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2015.

Based on DAFNA Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.